Article Data

  • Views 1252
  • Dowloads 190

Case Reports

Open Access

Cancer of unknown origin in gynaecologic oncology

  • Martina Romanova1
  • Jaroslav Klat1,*,

1Department of Obstetrics and Gynaecology, Oncogyneacological centre, University Hospital Ostrava, Ostrava, Czech Republic

DOI: 10.22514/ejgo.2023.045 Vol.44,Issue 3,June 2023 pp.102-105

Submitted: 13 November 2022 Accepted: 08 December 2022

Published: 15 June 2023

*Corresponding Author(s): Jaroslav Klat E-mail: Jaroslav.klat@fno.cz

Abstract

Tumour of unknown primary (primum ignotum) is a metastatic disease that generally shows a poor response to treatment and prognosis. Although it exhibits a trend of decreasing incidence, the diagnostic processes are complicated. The available literature shows that 5–30% of metastases involve the ovary, but it remains unclear how often ovarian infiltration is found in tumours of unknown primary. The most common metastatic disease that affects the ovaries are malignant tumours of the gastrointestinal tract, breast, pancreas, and haematological malignancies. Usually, the first step to distinguish between a primary and a secondary tumour of the ovary is an ultrasound examination, where the ovarian metastases have some characteristic features. Here we report our experience with primum ignotum in a patient with simultaneous ovarian and bone marrow involvement.


Keywords

Primum ignotum; Krukenberg tumour; Ovarian metastases


Cite and Share

Martina Romanova,Jaroslav Klat. Cancer of unknown origin in gynaecologic oncology. European Journal of Gynaecological Oncology. 2023. 44(3);102-105.

References

[1] Vikeså J, Møller AK, Kaczkowski B, Borup R, Winther O, Henao R, et al. Cancers of unknown primary origin (CUP) are characterised by chromosomal instability (CIN) compared to metastasis of known origin. BMC Cancer. 2015; 15: 151.

[2] Fizazi K, Greco FA, Pavlidis N, Daugaard G, Oien K, Pentheroudakis G, et al; ESMO Guidelines Committee. Cancers of the unknown primary site: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2015; 26: v133–8.

[3] Sugarbaker PH. Peritoneal carcinomatosis of an unknown primary site may be an undiagnosed appendiceal adenocarcinoma. A case series. International Journal of Surgery Case Reports. 2019; 63: 65–68.

[4] Laprovitera N, Riefolo M, Ambrosini E, Klec C, Pichler M, Ferracin M. Cancer of unknown primary: challenges and progress in clinical management. Cancers. 2021; 13: 451.

[5] Safri LS, Md Noh MSF, Hariz Ramli AR, Md Pauzi SH, Md Idris MA, Harunarashid H. A case of metastatic adenocarcinoma from an unknown primary involving the aortic bifurcation. Journal of Vascular Surgery Cases, Innovations and Techniques. 2018; 4: 160–162.

[6] Golfinopoulos V, Pentheroudakis G, Salanti G, Nearchou AD, Ioannidis JP, Pavlidis N. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: a multiple-treatments meta-analysis. Cancer Treatment Reviews. 2009; 35: 570–3.

[7] Testa AC, Ferrandina G, Timmerman D, Savelli L, Ludovisi M, Van Holsbeke C, et al. Imaging in gynaecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumour. Ultrasound in Obstetrics & Gynecology. 2007; 29: 505–11.

[8] Greco FA, Lennington WJ, Spigel DR, Hainsworth JD. Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology. Journal of the National Cancer Institute. 2013; 105: 782–90.

[9] Shah B, Tang W, Karn S. An up-to-date understanding of the “krukenberg tumor” mechanism. Advances in Reproductive Sciences. 2016; 4: 31–36.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top